Postpartum Hemorrhage: A Recurring Pregnancy Complication

Seminars in Perinatology

Volumn 31, Issue 3, 2007, Pages 159-166

  Kominiarek, Michelle A ^a   Kilpatrick, Sarah J ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

coagulation disorders; postpartum hemorrhage; prevention; recurrence; retained placenta; risk factors

Indexed keywords

CARBOPROST; ERGOMETRINE; METHYLERGOMETRINE; MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN; PROSTAGLANDIN E2; SULPROSTONE; UTEROTONIC AGENT;

BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CONTROLLED CLINICAL TRIAL; DRUG WITHDRAWAL; FEMALE; HUMAN; MATERNAL MORTALITY; PLACENTAL DELIVERY; POSTPARTUM HEMORRHAGE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETAINED PLACENTA; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; UTERINE ARTERY EMBOLIZATION; UTERUS INVERSION;

FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; PRENATAL CARE; RECURRENCE; RISK FACTORS;

EID: 34248651214     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2007.03.001     Document Type: Review

References (74)

1. AbouZahr C. Global burden of maternal death and disability. Br Med Bull 67 (2003) 1-11
2. Combs C.A., Murphy E.L., and Laros R.K. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 77 (1991) 69-76
3. Doran J.R., O'Brien S.A., and Randall J.H. Repeated postpartum hemorrhage. Obstet Gynecol 5 (1955) 186-192
4. Jansen A.J.G., van Rhenen D.J., Steegers E.A.P., et al. Postpartum hemorrhage and transfusion of blood and blood components. Obstet Gynecol Surv 60 (2005) 663-671
5. Hoveyda F., and MacKenzie I.Z. Secondary postpartum haemorrhage: incidence, morbidity and current management. Br J Obstet Gynaecol 108 (2002) 927-930
6. King P.A., Duthie S.J., Dong Z.G., et al. Secondary postpartum hemorrhage. Aust NZ J Obstet Gynaecol 29 (1989) 394-398
7. Sheiner E., Sarid L., Levy A., et al. Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study. J Matern Fetal Neo Med 18 (2005) 149-154
8. Stones R.W., Paterson C.M., and Saunders N.J. Risk factors for major obstetric hemorrhage. Eur J Obstet Gynecol Reprod Biol 48 (1993) 15-18
9. Brinsden P.R., and Clark A.D. Postpartum haemorrhage after induced and spontaneous labour. Br Med J 2 (1978) 855-856
10. Tsu V.D. Postpartum haemorrhage in Zimbabwe: a risk factor analysis. Br J Obstet Gynaecol 100 (1993) 327-333
11. Hall M.H., Halliwell R., and Carr-Hill R. Concomitant and repeated happenings of complications of the third stage of labour. Br J Obstet Gynaecol 92 (1985) 732-738
12. Dewhurst C.J., and Dutton W.A.W. Recurrent abnormalities of the third stage of labour. Lancet 273 (1957) 764-767
13. Magann E.F., Evans S., Hutchinson M., et al. Postpartum hemorrhage after vaginal birth: an analysis of risk factors. Southern Med J 98 (2005) 419-422
14. Mongelli M. Secondary post-partum haemorrhage: a recurrent condition?. Clin Exp Obstet Gynecol 19 (1992) 97
15. Nizard J., Barrinque L., Frydman R., et al. Fertility and pregnancy outcomes following hypogastric artery ligation for severe post-partum haemorrhage. Hum Reprod 18 (2003) 844-848
16. Descargues G., Tinlot F.M., Douvrin F., et al. Menses, fertility and pregnancy after arterial embolization for the control of postpartum haemorrhage. Hum Reprod 19 (2004) 339-343
17. Stancato-Pasik A., Mitty H., Richard H.M., et al. Obstetric embolotherapy: effect on menses and pregnancy. Radiology 204 (1997) 791-793
18. Salomon L.J., De Tayrac R., Castaigne-Meary V., et al. Fertility and pregnancy outcome following pelvic arterial embolization for severe post-partum haemorrhage. A cohort study. Hum Reprod 18 (2003) 849-852
19. B-Lynch C., Coker A., Lawal A.H., et al. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy?. Five cases reported. Br J Obstet Gynaecol 104 (1997) 372-375
20. Api M., Api O., and Yayla M. Fertility after B-lynch suture and hypogastric artery ligation. Fertil Steril 84 (2005) 509
21. Goldberg J., Pereira L., and Berghella V. Pregnancy after uterine artery embolization. Obstet Gynecol 100 (2002) 869-872
22. Qidwai G.I., Caughey A.B., and Jacoby A.F. Obstetric outcomes in women with sonographically identified uterine leiomyomata. Obstet Gynecol 107 (2006) 376-382
23. Hasan F., Arumugam K., and Sivanesaratnam V. Uterine leiomyomata in pregnancy. Int J Gynecol Obstet 34 (1990) 45-48
24. Winer-Muram H.T., Muram D., and Gilleison M.S. Uterine myomas in pregnancy. J Can Assoc Radiol 35 (1984) 168-170
25. Muram D., Gillieson M.S., Walters J.H., et al. Myomas of the uterus in pregnancy: ultrasonographic follow-up. Am J Obstet Gynecol 138 (1980) 16-19
26. Roberts W.E., Fulp K.S., Morrison J.C., et al. The impact of leiomyomas on pregnancy. Aust NZ J Obstet Gynaecol 39 (1999) 43-47
27. Vergani P., Ghidini A., Stobelt N., et al. Do uterine leiomyomas influence pregnancy outcome. Am J Perinatol 11 (1994) 356-358
28. Lev-Toaff A.S., Coleman B.G., Arger P.H., et al. Leiomyomas in pregnancy: a sonographic study. Radiology 164 (1987) 375-380
29. Goldberg J., Pereira L., Berghella V., et al. Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol 191 (2004) 18-21
30. Carpenter T.T., and Walker W.J. Pregnancy following uterine artery embolisation for symptomatic fibroids: a series of 26 completed pregnancies. Br J Obstet Gynaecol 112 (2005) 321-325
31. Seracchioli R., Manuzzi L., Vianello F., et al. Obstetric and delivery outcome of pregnancies achieved after laparoscopic myomectomy. Fertil Steril 86 (2006) 159-165
32. Walker W.J., and McDowell S.J. Pregnancy after uterine artery emoblization for leiomyomata: a series of 56 completed pregnancies. Am J Obstet Gynecol 195 (2006) 1266-1271
33. Pron G., Mocarski E., Bennett J., et al. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol 105 (2005) 67-76
34. Tandberg A., Albrechtsen S., and Iversen O.E. Manual removal of the placenta: incidence and clinical significance. Acta Obstet Gynecol Scand 78 (1999) 33-36
35. VanBeekhuizen M.E., and Vierhout M.E. Risk of recurrence of retained placenta. Med Tijdschr Geneeskd 138 (1994) 2149-2152
36. Titiz H., Wallace A., and Voaklander D.C. Manual removal of the placenta: a case control study. Aust NZ J Obstet Gynaecol 41 (2001) 41-44
37. Platt L.D., and Druzin M.L. Acute puerperal inversion of the uterus. Am J Obstet Gynecol 141 (1981) 187-190
38. Watson P., Besch N., and Bowes W.A. Management of acute and subacute puerperal inversion of the uterus. Obstet Gynecol 55 (1980) 12-16
39. Miller N.F. Pregnancy following inversion of the uterus. Am J Obstet Gynecol 13 (1927) 307-322
40. Baskett T.F. Acute uterine inversion: a review of 40 cases. J Obstet Gynaecol Can 24 (2002) 953-956
41. Ramsahoye B.H., Davies S.V., Dasani H., et al. Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a review of the literature. Haemophilia 1 (1995) 140-144
42. Kadir R.A., Lee C.A., Sabin C.A., et al. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 105 (1998) 314-321
43. Greer I.A., Lowe G.D.O., Walker J.J., et al. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynecol 98 (1991) 909-918
44. Kirtava A., Crudder S., Dilley A., et al. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States. Haemophilia 10 (2004) 158-161
45. Kujovich J.L. Von Willebrand disease and pregnancy. J Thromb Haemost 3 (2005) 246-253
46. Kouides P.A., Phatak P.D., Burkart P., et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia 6 (2000) 643-648
47. Ragni M.V., Bontempo F.A., and Hassett A.C. von Willebrand disease and bleeding in women. Haemophilia 5 (1999) 313-317
48. Hundegger R., Husslein P., Berghammer P., et al. Postpartum bleeding and von Willebrand's disease. Arch Gynecol Obstet 266 (2002) 160-162
49. American College of Obstetricians and Gynecologists Committee Opinion #263. Von Willebrand's disease in gynecologic practice, 2001
50. American College of Obstetricians and Gynecologists Committee Opinion #329. Menstruation in girls and adolescents. Using the menstrual cycle as a vital sign, 2006
51. Girolami A., Randi M.L., Ruzzon E., et al. Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors. Acta Haematol 115 (2006) 58-63
52. Kadir R.A., O'Connell N.M., Economides D.L., et al. Screening for factor XI deficiency amongst pregnant women of Ashkenazi Jewish origin. Haemophilia 12 (2006) 625-628
53. Shpilherg O., Peretz H., Zivelin R., et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type 11) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood 85 (1995) 429-432
54. Bolton-Maggs P.H.B., Wan-Yin B.Y., McCraw A.H., et al. Inheritance and bleeding in factor XI deficiency. Br J Haemotol 69 (1988) 521-528
55. Kadir R.A., Economides D.L., Braithwaite J., et al. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol 104 (1997) 803-810
56. Maslovitz S., Many A., Landsberg J.A., et al. The safety of low molecular weight heparin therapy during labor. J Matern Fetal Neonat Med 17 (2005) 39-43
57. Rowan J.A., McLintock C., Taylor R.S., et al. Prophylactic and therapeutic enoxaparin during pregnancy: Indications, outcomes, and monitoring. Aust NZ J Obstet Gynecol 43 (2003) 123-128
58. Borna S., Borna H., and Zhazardoost S. Maternal and neonatal outcomes in pregnant women with immune thrombocytopenic purpura. Arch Iranian Med 9 (2006) 115-118
59. Hwa H.L., Wang T.R., Huang S.C., et al. Maternal and fetal outcome of pregnant women with idiopathic thrombocytopenic purpura: retrospective analysis of 25 cases. J Formos Med Assoc 92 (1993) 957-961
60. Lind J., and Wallenburg H.C.S. Pregnancy and the Ehlers-Danlos syndrome: a retrospective study in a Dutch population. Acta Obstet Gynecol Scand 81 (2002) 293-300
61. Volkov N., Nisenblat V., Ohel G., et al. Ehlers-Danlos syndrome: insights on obstetric aspects. Obstet Gynecol Surv 62 (2007) 51-57
62. Rosnes J.S., Sharkey M.F., Veille J.C., et al. Gaucher's disease in pregnancy. Obstet Gynecol Surv 51 (1996) 549-558
63. Young B.K., and Gorstein F. Maternal osteogenesis imperfecta. Obstet Gynecol 31 (1968) 461-470
64. Rahman J., al-Suleiman S.A., Rahman M.S., et al. Obstetric and gynecologic complications in women with Marfan syndrome. J Reprod Med 48 (2004) 723-728
65. Meijboom L., Drenthen W., Pieper P.G., et al. Obstetric complications in Marfan syndrome. Int J Card 110 (2006) 53-59
66. Jackson K.W., Allbert J.R., Schemmer G.K., et al. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol 185 (2001) 873-877
67. McCurdy C., Magann E., McCurdy C., et al. The effect of placental management at cesarean delivery on operative blood loss. Am J Obstet Gynecol 167 (1992) 1363
68. American College of Obstetricians and Gynecologists Practice Bulletin #76. Postpartum hemorrhage, 2006
69. VanSelm M., Kanhai H.H.H., and Keirse M. Preventing the recurrence of atonic postpartum hemorrhage: a double-blind trial. Acta Obstet Gynecol Scand 74 (1995) 270-274
70. Newton M., Mosey L.M., Egli G.E., et al. Blood loss during and immediately after delivery. Obstet Gynecol 17 (1961) 9-18
71. McVay P.A., Hoag R.W., Hoag M.S., et al. Safety and use of autologous blood donation during the third trimester of pregnancy. Am J Obstet Gynecol 160 (1989) 1479-1488
72. Herbert W.N., Owen H.G., and Collins M.L. Autologous blood storage in obstetrics. Obstet Gynecol 72 (1988) 166-170
73. Andres A.L., Piacquadio K.M., Resnik R., et al. A reappraisal of the need for autologous blood donation in the obstetric patient. Am J Obstet Gynecol 163 (1990) 1551-1552
74. Combs C.A., Murphy E.L., and Laros R.K. Cost-benefit analysis of autologous blood donation in obstetrics. Obstet Gynecol 80 (1992) 621-625